vs
Side-by-side financial comparison of Option Care Health, Inc. (OPCH) and Teradyne (TER). Click either name above to swap in a different company.
Option Care Health, Inc. is the larger business by last-quarter revenue ($1.4B vs $1.3B, roughly 1.1× Teradyne). Teradyne runs the higher net margin — 31.1% vs 3.4%, a 27.7% gap on every dollar of revenue. On growth, Teradyne posted the faster year-over-year revenue change (87.0% vs 1.3%). Over the past eight quarters, Teradyne's revenue compounded faster (32.6% CAGR vs 4.9%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Teradyne, Inc. is an American automatic test equipment (ATE) designer and manufacturer based in North Reading, Massachusetts. Its high-profile customers include Samsung, Qualcomm, Intel, Analog Devices, Texas Instruments and IBM.
OPCH vs TER — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.3B |
| Net Profit | $45.3M | $398.9M |
| Gross Margin | 19.4% | 60.9% |
| Operating Margin | 5.4% | 36.9% |
| Net Margin | 3.4% | 31.1% |
| Revenue YoY | 1.3% | 87.0% |
| Net Profit YoY | -3.0% | — |
| EPS (diluted) | $0.29 | $2.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.4B | $1.3B | ||
| Q4 25 | $1.5B | $1.1B | ||
| Q3 25 | $1.4B | $769.2M | ||
| Q2 25 | $1.4B | $651.8M | ||
| Q1 25 | $1.3B | $685.7M | ||
| Q4 24 | $1.3B | $752.9M | ||
| Q3 24 | $1.3B | $737.3M | ||
| Q2 24 | $1.2B | $729.9M |
| Q1 26 | $45.3M | $398.9M | ||
| Q4 25 | $58.5M | $257.2M | ||
| Q3 25 | $51.8M | $119.6M | ||
| Q2 25 | $50.5M | $78.4M | ||
| Q1 25 | $46.7M | $98.9M | ||
| Q4 24 | $60.1M | $146.3M | ||
| Q3 24 | $53.9M | $145.6M | ||
| Q2 24 | $53.0M | $186.3M |
| Q1 26 | 19.4% | 60.9% | ||
| Q4 25 | 19.3% | 57.2% | ||
| Q3 25 | 19.0% | 58.4% | ||
| Q2 25 | 19.0% | 57.2% | ||
| Q1 25 | 19.7% | 60.6% | ||
| Q4 24 | 21.3% | 59.4% | ||
| Q3 24 | 20.1% | 59.2% | ||
| Q2 24 | 20.3% | 58.3% |
| Q1 26 | 5.4% | 36.9% | ||
| Q4 25 | 6.2% | 27.1% | ||
| Q3 25 | 5.9% | 18.9% | ||
| Q2 25 | 5.8% | 13.9% | ||
| Q1 25 | 5.9% | 17.6% | ||
| Q4 24 | 6.9% | 20.4% | ||
| Q3 24 | 6.7% | 20.6% | ||
| Q2 24 | 6.6% | 28.8% |
| Q1 26 | 3.4% | 31.1% | ||
| Q4 25 | 4.0% | 23.7% | ||
| Q3 25 | 3.6% | 15.5% | ||
| Q2 25 | 3.6% | 12.0% | ||
| Q1 25 | 3.5% | 14.4% | ||
| Q4 24 | 4.8% | 19.4% | ||
| Q3 24 | 4.2% | 19.8% | ||
| Q2 24 | 4.3% | 25.5% |
| Q1 26 | $0.29 | $2.53 | ||
| Q4 25 | $0.37 | $1.62 | ||
| Q3 25 | $0.32 | $0.75 | ||
| Q2 25 | $0.31 | $0.49 | ||
| Q1 25 | $0.28 | $0.61 | ||
| Q4 24 | $0.36 | $0.89 | ||
| Q3 24 | $0.31 | $0.89 | ||
| Q2 24 | $0.30 | $1.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.3M | $241.9M |
| Total DebtLower is stronger | — | $0 |
| Stockholders' EquityBook value | — | — |
| Total Assets | $3.4B | $4.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $177.3M | $241.9M | ||
| Q4 25 | $232.6M | $293.8M | ||
| Q3 25 | $309.8M | $272.7M | ||
| Q2 25 | $198.8M | $339.3M | ||
| Q1 25 | $171.4M | $475.6M | ||
| Q4 24 | $412.6M | $553.4M | ||
| Q3 24 | $483.0M | $510.0M | ||
| Q2 24 | $376.9M | $421.9M |
| Q1 26 | — | $0 | ||
| Q4 25 | — | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | $2.8B | ||
| Q3 25 | $1.4B | $2.7B | ||
| Q2 25 | $1.4B | $2.8B | ||
| Q1 25 | $1.4B | $2.8B | ||
| Q4 24 | $1.4B | $2.8B | ||
| Q3 24 | $1.4B | $2.9B | ||
| Q2 24 | $1.4B | $2.7B |
| Q1 26 | $3.4B | $4.4B | ||
| Q4 25 | $3.5B | $4.2B | ||
| Q3 25 | $3.5B | $4.0B | ||
| Q2 25 | $3.4B | $3.8B | ||
| Q1 25 | $3.3B | $3.7B | ||
| Q4 24 | $3.4B | $3.7B | ||
| Q3 24 | $3.4B | $3.8B | ||
| Q2 24 | $3.3B | $3.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.86× | — | ||
| Q2 25 | 0.82× | — | ||
| Q1 25 | 0.82× | — | ||
| Q4 24 | 0.79× | — | ||
| Q3 24 | 0.78× | — | ||
| Q2 24 | 0.79× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $265.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 0.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $265.1M | ||
| Q4 25 | $258.4M | $281.6M | ||
| Q3 25 | $139.4M | $49.0M | ||
| Q2 25 | $90.3M | $182.1M | ||
| Q1 25 | $-7.2M | $161.6M | ||
| Q4 24 | $36.1M | $282.6M | ||
| Q3 24 | $160.4M | $166.3M | ||
| Q2 24 | $195.7M | $216.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $218.8M | ||
| Q3 25 | $130.2M | $2.4M | ||
| Q2 25 | $81.2M | $131.7M | ||
| Q1 25 | $-16.6M | $97.6M | ||
| Q4 24 | $25.8M | $225.2M | ||
| Q3 24 | $150.7M | $114.4M | ||
| Q2 24 | $185.9M | $171.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 20.2% | ||
| Q3 25 | 9.1% | 0.3% | ||
| Q2 25 | 5.7% | 20.2% | ||
| Q1 25 | -1.2% | 14.2% | ||
| Q4 24 | 2.0% | 29.9% | ||
| Q3 24 | 11.8% | 15.5% | ||
| Q2 24 | 15.1% | 23.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.8% | ||
| Q3 25 | 0.6% | 6.1% | ||
| Q2 25 | 0.6% | 7.7% | ||
| Q1 25 | 0.7% | 9.3% | ||
| Q4 24 | 0.8% | 7.6% | ||
| Q3 24 | 0.8% | 7.0% | ||
| Q2 24 | 0.8% | 6.1% |
| Q1 26 | — | 0.66× | ||
| Q4 25 | 4.42× | 1.09× | ||
| Q3 25 | 2.69× | 0.41× | ||
| Q2 25 | 1.79× | 2.32× | ||
| Q1 25 | -0.15× | 1.63× | ||
| Q4 24 | 0.60× | 1.93× | ||
| Q3 24 | 2.98× | 1.14× | ||
| Q2 24 | 3.69× | 1.16× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
